How we secured a COVID‐19 convalescent plasma procurement scheme in Japan

…, T Togano, S Saito, N Kinoshita, Y Shimanishi… - …, 2021 - Wiley Online Library
Background In order to tackle the COVID‐19 pandemic, a COVID‐19 convalescent plasma (CCP)
procurement program was initiated in Japan in April 2020. The program was a …

Factors associated with development and persistence of post-COVID conditions: A cross-sectional study

…, M Terada, S Kutsuna, S Saito, Y Shimanishi… - Journal of Infection and …, 2022 - Elsevier
Introduction The post-COVID condition has become a social concern. Although the patient
characteristics associated with the development of this condition are partially known, those …

Risk factors associated with development and persistence of long COVID

…, S Morioka, M Terda, S Kutsuna, S Saito, Y Shimanishi… - Medrxiv, 2021 - medrxiv.org
Background Long COVID has been a social concern. Though patient characteristics associated
with developing long COVID are partially known, those associated with persisting it have …

Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan

…, S Ide, S Fukuda, A Tanaka, Y Shimanishi… - Journal of Infection and …, 2022 - Elsevier
Introduction The ability to predict which patients with a history of coronavirus disease (COVID-19)
will exhibit a high antibody titer is necessary for more efficient screening of potential …

Safety of convalescent plasma therapy for COVID-19 patients and analysis of viral kinetics: a single-center, open-label, single-arm, interventional study in Japan

…, E Ikebe, K Okuma, I Hamaguchi, Y Shimanishi… - GHM Open, 2022 - jstage.jst.go.jp
Convalescent plasma therapy is an important treatment method for patients with severe
coronavirus disease (COVID-19). This study was conducted to confirm the safety of this therapy. …

[PDF][PDF] Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved

…, Y Asai, K Takahashi, M Sanada, Y Shimanishi… - Heliyon, 2023 - cell.com
Background We aimed to investigate chronological changes in the characteristics of participants
in a coronavirus disease 2019 convalescent plasma donation study that may benefit …

[HTML][HTML] Risk Factors Associated with Development and Persistence of Long COVID: A Cross-Sectional Study

…, M Terada, S Kutsuna, S Saito, Y Shimanishi… - 2021 - europepmc.org
Background: Long coronavirus disease (COVID) has been a social concern. Though patient
characteristics associated with the development of long COVID are partially known, those …

Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants

M Ueno, N Iwata-Yoshikawa, A Matsunaga… - Antiviral Research, 2022 - Elsevier
Monoclonal antibody therapy is a promising option for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, and a cocktail of antibodies (REGN-COV) has been …

Labor Oral History in Japan

O UMEZAKI - Japanese Research in Business History, 2019 - jstage.jst.go.jp
The purpose of this article is to present a comprehensive picture of labor oral history studies
which have accumulated in Japan and to show labor oral history’s possibility to bring new …

Books on Japanese Business History Published in 2011

K Arakawa, T Demizu, M Hayashi - jstage.jst.go.jp
Thailand and his ties to Japanese companies active in the country, Kawabe delved into his
research on how a Japanese company–Toyota Motor Thailand–became an independent …